X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7265) 7265
Book Review (665) 665
Newsletter (416) 416
Publication (397) 397
Book Chapter (44) 44
Newspaper Article (37) 37
Conference Proceeding (29) 29
Dissertation (10) 10
Magazine Article (7) 7
Book / eBook (3) 3
Paper (3) 3
Data Set (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5076) 5076
cyclodextrins (3331) 3331
pharmacology & pharmacy (2713) 2713
animals (2458) 2458
humans (2202) 2202
cyclodextrin (1812) 1812
solubility (1581) 1581
male (1542) 1542
beta-cyclodextrin (1500) 1500
beta-cyclodextrins - chemistry (1050) 1050
drug delivery systems (1042) 1042
rats (964) 964
chemistry, multidisciplinary (951) 951
drugs (927) 927
female (927) 927
nanoparticles (856) 856
cyclodextrins - chemistry (827) 827
2-hydroxypropyl-beta-cyclodextrin (782) 782
mice (763) 763
analysis (722) 722
bioavailability (680) 680
in-vitro (618) 618
beta-cyclodextrins (608) 608
drug-delivery (585) 585
chemistry, medicinal (584) 584
chemistry (542) 542
inclusion complex (538) 538
dextrins (526) 526
delivery (520) 520
pharmacokinetics (518) 518
biological availability (512) 512
administration, oral (502) 502
chemistry, pharmaceutical (502) 502
vehicles (497) 497
drug carriers - chemistry (490) 490
hydroxypropyl-beta-cyclodextrin (455) 455
research (454) 454
β-cyclodextrin (451) 451
inclusion complexes (436) 436
biochemistry & molecular biology (431) 431
cancer (430) 430
particle size (430) 430
drug stability (424) 424
chemistry, analytical (406) 406
pharmacy (401) 401
release (396) 396
complexation (393) 393
adult (386) 386
polymers (386) 386
stability (382) 382
cyclodextrins - administration & dosage (377) 377
dissolution (372) 372
formulation (367) 367
rats, sprague-dawley (357) 357
absorption (354) 354
drug delivery (354) 354
permeability (353) 353
calorimetry, differential scanning (351) 351
organic chemistry (351) 351
polymer science (332) 332
hydrogen-ion concentration (329) 329
derivatives (326) 326
nanoparticles - chemistry (324) 324
pharmaceutical applications (322) 322
anesthesiology (320) 320
cell line, tumor (317) 317
cholesterol (317) 317
x-ray diffraction (317) 317
drug carriers (308) 308
materials science, biomaterials (302) 302
chemistry, applied (301) 301
rats, wistar (299) 299
chemistry, organic (298) 298
middle aged (297) 297
dose-response relationship, drug (291) 291
excipients - chemistry (285) 285
beta-cyclodextrins - administration & dosage (282) 282
drug compounding (282) 282
rabbits (279) 279
chemistry, physical (278) 278
cyclodextrins - pharmacology (275) 275
kinetics (275) 275
pharmacology/toxicology (275) 275
food science (266) 266
beta-cyclodextrins - pharmacology (262) 262
alpha-cyclodextrin (261) 261
time factors (257) 257
biochemistry, general (255) 255
drug (251) 251
biomedicine (248) 248
chitosan (248) 248
spectroscopy, fourier transform infrared (243) 243
in-vivo (234) 234
drug delivery systems - methods (232) 232
chemistry, pharmaceutical - methods (231) 231
liposomes (231) 231
encapsulation (229) 229
health aspects (229) 229
cells (227) 227
hydroxypropyl-β-cyclodextrin (226) 226
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7558) 7558
Japanese (82) 82
Chinese (59) 59
French (27) 27
German (10) 10
Russian (10) 10
Italian (7) 7
Spanish (7) 7
Hungarian (5) 5
Portuguese (4) 4
Croatian (2) 2
Korean (2) 2
Polish (2) 2
Bosnian (1) 1
Czech (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Colloids and Surfaces B: Biointerfaces, ISSN 0927-7765, 09/2016, Volume 145, pp. 241 - 250
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 01/2012, Volume 80, Issue 1, pp. 46 - 53
A new delivery system based on drug cyclodextrin (Cd) complexation and loading into nanostructured lipid carriers (NLC) has been developed to improve... 
Nanostructured lipid carriers (NLC) | Polymeric cyclodextrins | Hydrogel | Topical formulation | Ketoprofen | VIVO | NLC | NANOPARTICLES SLN | TRANSDERMAL DELIVERY | COMPLEXES | INDOMETHACIN | SOLID-STATE | IN-VITRO | BETA-CYCLODEXTRIN | PHARMACOLOGY & PHARMACY | NAPROXEN | Polymers - administration & dosage | Chemistry, Pharmaceutical - methods | Hydrogel, Polyethylene Glycol Dimethacrylate - chemistry | Drug Carriers - administration & dosage | Delayed-Action Preparations - chemistry | Drug Carriers - chemistry | Delayed-Action Preparations - administration & dosage | Ketoprofen - chemistry | Lipids - chemistry | Hydrogel, Polyethylene Glycol Dimethacrylate - administration & dosage | Cyclodextrins - chemistry | Epichlorohydrin - administration & dosage | Polysaccharides, Bacterial - chemistry | Polysaccharides, Bacterial - administration & dosage | Freeze Drying - methods | Drug Stability | Solubility | Ketoprofen - administration & dosage | Lipids - administration & dosage | Permeability | Particle Size | Epichlorohydrin - chemistry | beta-Cyclodextrins - administration & dosage | beta-Cyclodextrins - chemistry | Nanostructures - administration & dosage | Cyclodextrins - administration & dosage | Nanostructures - chemistry | Polymers - chemistry | Administration, Topical | Cyclodextrins | Dextrins | Transdermal medication | Index Medicus
Journal Article
Experimental Physiology, ISSN 0958-0670, 06/2018, Volume 103, Issue 6, pp. 916 - 923
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 02/2017, Volume 518, Issue 1-2, pp. 193 - 202
In this study, a new type of mixed micelles was developed using Soluplus (SOL) and Pluronic P105 (P105) for the encapsulation of Oridonin (ORN).... 
Soluplus | Bioavailability | Micelles | Oridonin | Pluronic® P105 | Pluronic | P105 | SUPERSATURATED POLYMERIC MICELLES | Pluronic (R) P105 | DRUG-RELEASE | OVARIAN-CANCER | CYCLODEXTRIN INCLUSION COMPLEX | CYCLOSPORINE-A DELIVERY | Soluplus (R) | TUMOR SPHEROIDS | BETA-CYCLODEXTRIN | PHARMACOLOGY & PHARMACY | IN-VIVO EVALUATION | HOT-MELT EXTRUSION | SUSTAINED-RELEASE | Humans | Spheroids, Cellular - pathology | Drug Carriers - administration & dosage | Biological Availability | Male | Polyethylene Glycols - chemistry | Drug Carriers - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Polyvinyls - pharmacokinetics | Spheroids, Cellular - drug effects | Antineoplastic Agents, Phytogenic - pharmacokinetics | Poloxamer - administration & dosage | Diterpenes, Kaurane - chemistry | Poloxamer - chemistry | Cell Survival - drug effects | Administration, Oral | Poloxamer - pharmacokinetics | Polyethylene Glycols - pharmacokinetics | Antineoplastic Agents, Phytogenic - chemistry | Rats, Sprague-Dawley | Polyethylene Glycols - administration & dosage | Particle Size | Animals | Polyvinyls - administration & dosage | Diterpenes, Kaurane - pharmacokinetics | Mice, Nude | Cell Line, Tumor | Drug Liberation | Drug Carriers - pharmacokinetics | Diterpenes, Kaurane - administration & dosage | Polyvinyls - chemistry | Index Medicus
Journal Article
Biomacromolecules, ISSN 1525-7797, 05/2014, Volume 15, Issue 5, pp. 1768 - 1776
We have developed herein an engineered polymer-based nanoplatform showing the convergence of two-photon fluorescence imaging and bimodal phototherapeutic... 
POLYMER SCIENCE | EQUILIBRIUM-CONSTANTS | NITRIC-OXIDE RELEASE | DRUG-DELIVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | BLOCK-COPOLYMER MICELLES | ZINC PHTHALOCYANINE | THERAPY | BETA-CYCLODEXTRIN POLYMER | MULTIWAVELENGTH SPECTROSCOPIC DATA | INCLUSION COMPLEX | WATER | Polymers - administration & dosage | Photosensitizing Agents - chemistry | Skin Neoplasms - drug therapy | Nanoparticles - chemistry | Antineoplastic Agents - chemical synthesis | Biocompatible Materials - chemistry | Carcinoma, Squamous Cell - pathology | Humans | Drug Carriers - administration & dosage | Antineoplastic Agents - administration & dosage | Drug Carriers - chemistry | Indoles - administration & dosage | Biocompatible Materials - chemical synthesis | Photosensitizing Agents - administration & dosage | Drug Carriers - radiation effects | Singlet Oxygen - metabolism | Nanoparticles - radiation effects | Photosensitizing Agents - pharmacology | Polymers - radiation effects | Antineoplastic Agents - pharmacology | Molecular Structure | Epichlorohydrin - administration & dosage | Photosensitizing Agents - chemical synthesis | Skin Neoplasms - pathology | Cell Survival - drug effects | Nitric Oxide - chemistry | Polymers - chemical synthesis | Photons | Antineoplastic Agents - chemistry | Epichlorohydrin - chemistry | Carcinoma, Squamous Cell - drug therapy | beta-Cyclodextrins - administration & dosage | beta-Cyclodextrins - chemistry | Biocompatible Materials - radiation effects | Singlet Oxygen - chemistry | Cell Line, Tumor | Organometallic Compounds - chemistry | Polymers - chemistry | Biocompatible Materials - administration & dosage | Cell Proliferation - drug effects | Nanoparticles - administration & dosage | Nitric Oxide - metabolism | Indoles - chemistry | Microscopy, Fluorescence | Drug Screening Assays, Antitumor | Organometallic Compounds - administration & dosage | Index Medicus | Materials Chemistry | Biofysik | Fysikalisk kemi | Biophysics | Physical Chemistry | Materialkemi
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 08/2014, Volume 87, Issue 3, pp. 579 - 588
Journal Article
INTERNATIONAL JOURNAL OF PHARMACEUTICS, ISSN 0378-5173, 04/2017, Volume 521, Issue 1-2, pp. 73 - 83
An innovative pediatric oral formulation of hydrochlorothiazide (HCT) (2 mg/mL), endowed with improved bioavailability and sustained release properties and... 
VITRO | Pediatrics | Oral bioavailability | DIURETIC ACTIVITY | NLC | STABILITY | COMPLEXES | CONTROLLED DRUG-DELIVERY | Hydrochlorothiazide | CARRIERS | Cyclodextrin | SLN | PHYSICOCHEMICAL CHARACTERIZATION | BETA-CYCLODEXTRIN | Sustained release | PHARMACOLOGY & PHARMACY | Solid lipid nanoparticles | Hydrochlorothiazide - pharmacokinetics | Nanoparticles - chemistry | Antihypertensive Agents - administration & dosage | Drug Carriers - administration & dosage | Biological Availability | Delayed-Action Preparations - chemistry | Hypertension - drug therapy | Lipids | Male | Drug Carriers - chemistry | Delayed-Action Preparations - administration & dosage | Nanoparticles - metabolism | Cyclodextrins - chemistry | Drug Compounding | Poloxamer - administration & dosage | Poloxamer - chemistry | Drug Evaluation, Preclinical - methods | Administration, Oral | Poloxamer - pharmacokinetics | Cyclodextrins - pharmacokinetics | Hydrochlorothiazide - chemistry | Rats | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - pharmacokinetics | Rats, Sprague-Dawley | Hypertension - metabolism | Antihypertensive Agents - chemistry | Animals | Cyclodextrins - administration & dosage | Pediatrics - methods | Nanoparticles - administration & dosage | Hypertension | Product enhancement | Analysis | Diuretics | Cyclodextrins | Dextrins | Nanoparticles | Surface active agents | Drug therapy, Combination | Children | Health aspects | Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 01/2015, Volume 197, pp. 29 - 40
Stealth active targeting nanoparticles (NPs) usually include two types of ligand sites: ligand anchored on distal ends of the polyethylene glycol (PEG) and... 
Long circulation times | Cellular uptake | Hyaluronic acid | Pegylation | Host–guest interaction | Host-guest interaction | DRUG-DELIVERY | MICELLES | PEG CHAIN-LENGTH | CHEMISTRY, MULTIDISCIPLINARY | PACLITAXEL | BREAST-CANCER | NANOPARTICLES | SURFACE-DENSITY | IN-VIVO | PHARMACOLOGY & PHARMACY | SIRNA | LIPOSOMES | 2-Hydroxypropyl-beta-cyclodextrin | Neoplasms - metabolism | Nanoparticles - chemistry | Humans | Drug Carriers - administration & dosage | Male | Polyethylene Glycols - chemistry | Topoisomerase II Inhibitors - administration & dosage | Doxorubicin - chemistry | Drug Carriers - chemistry | Antibiotics, Antineoplastic - chemistry | Topoisomerase II Inhibitors - chemistry | Hyaluronan Receptors - metabolism | Antibiotics, Antineoplastic - pharmacokinetics | Doxorubicin - administration & dosage | Cell Survival - drug effects | Hyaluronic Acid - administration & dosage | Hyaluronic Acid - chemistry | Rats, Sprague-Dawley | Doxorubicin - pharmacokinetics | Polyethylene Glycols - administration & dosage | Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Animals | beta-Cyclodextrins - chemistry | Tumor Burden - drug effects | Cell Line, Tumor | Topoisomerase II Inhibitors - pharmacokinetics | Drug Carriers - pharmacokinetics | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Neoplasms - pathology | Anthracyclines | Cyclodextrins | Polyols | Investigations | Drugs | Drug delivery systems | Polyethylene glycol | Vehicles | Index Medicus
Journal Article